Effects of AI Assisted Follow-up Strategy on Secondary Prevention in CABG Patients
Effects of AI Assisted Follow-up Strategy on Secondary Prevention in CABG Patients
The present study is trying to find out whether artificial intelligence assisted follow-up
 strategy will improve secondary prevention in CABG patients. In addition, we will test
 whether rural patients may have more benefits under the new follow-up strategy based on the
 artificial intelligence device compared with urban patients.
There are a large population of coronary heart disease patients in China, which needs more
 attention to optimize the secondary prevention and improve the prognosis. Secondary
 prevention has been showing the effects of improving symptoms, preventing disease
 progression, improving prognosis, and reducing mortality in patients received coronary artery
 bypass grafting (CABG) surgery. In this study, we are trying to evaluate the effectiveness of
 artificial intelligence (AI) assisted follow-up strategy on secondary prevention for patients
 received CABG surgery. And we are trying to find out whether there is difference in secondary
 prevention of coronary heart disease between urban and rural patients.
Inclusion Criteria:

 1. Age between 18-70, male or female

 2. Received isolated CABG procedure due to coronary artery disease

 3. Having a smartphone and are willing to cooperate

 4. Signing written informed consent

 Exclusion Criteria:

 1. Patients undergoing CABG + valve replacement surgery

 2. Postoperative hospital stays more than 10 days (Due to limited postoperative follow-up
 time and unstable condition such as incision infection, angina, etc.)

 3. Patients with lung, liver, and kidney failure (Due to organ dysfunction which needs
 more professional health care and not suitable for this trial)

 4. Patients with Urinary system diseases (Getting up during sleep, which will interfere
 with sleep monitoring)

 5. Patients mentally or legally disabled

 6. Breastfeeding or pregnant women

 7. End-stage disease, estimated survival time is less than 3 months

 8. Participate in other perioperative intervention studies at the same time